Skip to main content
. Author manuscript; available in PMC: 2023 Dec 21.
Published in final edited form as: J Hepatol. 2023 May 8;79(3):853–866. doi: 10.1016/j.jhep.2023.04.033

Table 2.

A summary of drugs suspected of causing DILI.

Highly probable drug and HDS association (n = 18) Possible drug association (n = 4) Reported but unproven (n = 21) Reported only in the 1970s and 1980s (n = 15)
Nitrofurantoin14 Etanercept21 Cephalexin14 Halothane4
Minocycline14 Efalizumab21 Clometacine4 Tienilic cacid4
Methyldopa20 Atovaquone/Proguanil84 Echinacea4 Oxiphensation4
Hydralazine20 Turmeric21 Pemoline4 Sulfonamide4
Infliximab35 Ma Huang21 Propylthiouracil4
Interferon-α & β 21 Prometrium14 Isoniazid4
Atorvastatin20 Hydroxycut4 Dantrolene4
Simvastatin20 Meloxicam4 Perhexiline maleate4
Fluvastatin20 Methotrexate4 Amiodarone4
Rosuvastatin20 N-Nitroso-fenfluramine4 Papaverine4
Imatinib21 Ambrisentan4 Benzarone4
Masitinib21 Glucosamine/chondroitin sulfate4 Terbinafine4
Adalimumab21 Camostat/benzbromarone4 Methylphenidate4
Diclofenac21 Xiang-tian-guo4 Bupropion4
Methylprednisolone21 Indometacin4 Olmesartan4
Cyproterone4 Varenicline21
Khat21 Menotrophin21
Tinospora cordifola21,83 Indometacin4
Fenofibrate4
Pazopanib4
Phenprocoumon4

Drugs with well documented DI-ALH (strong association), with convincing reports, that have been analysed and undergone causality assessment; possible DI-ALH with several reports that suggest a relationship but do not fulfil criteria proposed in a recent paper on DI-ALH,24 those that have been reported, mostly in single reports, with short follow-up and/or important clinical information lacking. Finally, drugs suspected to have induced DI-ALH but only in the 1970s and 1980s, before the detection of hepatitis C and with competing causes often not excluded. References are in parentheses.